相关实验视频
Updated: May 29, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
270
肥胖的医疗管理:释放潜在的潜力
Angie S Xiang1, Priya Sumithran1,2
1Department of Endocrinology and Diabetes, Alfred Health, Melbourne, VIC, Australia.
Climacteric : the journal of the International Menopause Society
|February 7, 2025
概括
针对肠道激素的新型肥胖药物可显著减肥,改善心血管健康. 这些进展显示出治疗相关疾病的前景,但获得治疗仍然是一个挑战.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 肥胖是一种复杂的慢性疾病,长期治疗效果有限.
- 以前用于肥胖的药物治疗方法具有适度的疗效和耐受性问题.
- 最近的进展集中在准肠-大脑轴和荷尔蒙调节.
研究的目的:
- 审查最近肥胖药物治疗方面的突破.
- 突出新型肠道激素向剂的有效性和安全性.
- 讨论这些新药的更广泛的健康益处和获取挑战.
主要方法:
- 对新型肥胖药物的临床试验数据的审查.
- 对研究对体重,代谢参数和并发症的影响的分析.
- 检查有关心血管,和肝脏益处的证据.
主要成果:
- 针对肠道激素受体的新型药物实现了显著的体重减轻 (通常>15%).
- 观察到心血管风险因素,2型糖尿病和非酒精性脂肪肝疾病的显著改善.
- 益处延伸到阻塞性睡眠呼吸暂停和慢性病,与减肥手术结果相竞争.
结论:
- 基于肠道激素的药物代表了对肥胖管理的重大治疗进展.
- 这些药物提供全面的代谢和心血管益处,解决多种并发症.
- 公平获得这些变革性的肥胖治疗方法对公共卫生至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Obesity
366
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
366
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60
Binge Eating Disorders
46
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
46

